Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac β-adrenoceptor system in experimental heart failure

被引:40
作者
Leineweber, K
Brandt, K
Wludyka, B
Beilfuss, A
Pönicke, K
Heinroth-Hoffmann, I
Brodde, OE
机构
[1] Univ Essen Gesamthsch, Sch Med, Inst Pathophysiol, D-45147 Essen, Germany
[2] Univ Halle Wittenberg, Inst Pharmacol, Halle An Der Saale, Germany
关键词
monocrotaline; right heart hypertrophy; neurohumoral activation; beta-adrenoceptor; G protein-coupled receptor kinase;
D O I
10.1161/01.RES.0000045088.59360.B7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment of rats with monocrotaline (MCT) leads to pulmonary hypertension, right ventricular (RV) hypertrophy, and finally to RV heart failure. This is associated with characteristic changes in right ventricular beta-adrenoceptors (beta-AR), neuronal noradrenaline transporter (NAT) density and activity (uptake(1)), and G protein-coupled receptor kinase (GRK) activity. This study aimed to find out factors that determine beta-AR, uptake(1), and GRK changes. Thus, 6-week-old rats were treated with 50 mg/kg MCT subcutaneous or 0.9% saline. Within 13 to 19 days after MCT application (group A), RV weight (222 +/- 6 versus 147 +/- 5 mg) and RV/left ventricular (LV) weight ratio (0.42 +/- 0.01 versus 0.29 +/- 0.01) were significantly increased, whereas plasma noradrenaline, RV beta-AR density, RV NAT density and activity, and RV GRK activity were not significantly altered. Twenty-one to twenty-eight days after MCT (group B), however, not only RV weight (316 +/- 4 versus 149 +/- 2 mg) and RV/LV weight ratio (0.61 +/- 0.01 versus 0.3 +/- 0.01) were markedly increased but also plasma noradrenaline (645 +/- 63 versus 278 +/- 18 pg/mL); now, RV beta-AR density (13.4 +/- 1.3 versus 26.5 +/- 1.1 fmol/mg protein), RV NAT density (50.9 +/- 11.3 versus 79.6 +/- 2.9 fmol/mg protein), and RV NAT activity (65.4 +/-7.4 versus 111.8 +/- 15.9 pmol [H-3]-NA/mg tissue slices/15 min) were significantly decreased and RV-membrane GRK activity (100 +/- 15 versus 67 +/- 6 [P-32]-rhodopsin in cpm) significantly increased. LV parameters of MCT-treated rats were only marginally different from control LV. We conclude that in MCT-treated rats ventricular hypertrophy per se is not sufficient to cause characteristic alterations in the myocardial beta-AR system often seen in heart failure, only if ventricular hypertrophy is associated with neurohumoral activation beta-ARs are downregulated and GRK activity is increased.
引用
收藏
页码:1056 / 1062
页数:7
相关论文
共 32 条
[1]  
Abraham G, 2001, N-S ARCH PHARMACOL, V363, pR97
[2]   EVIDENCE FOR REDUCTION OF NOREPINEPHRINE UPTAKE SITES IN THE FAILING HUMAN HEART [J].
BOHM, M ;
LAROSEE, K ;
SCHWINGER, RHG ;
ERDMANN, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (01) :146-153
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BRISTOW MR, 1989, MOL PHARMACOL, V35, P295
[5]   BETA-ADRENERGIC NEUROEFFECTOR ABNORMALITIES IN THE FAILING HUMAN HEART ARE PRODUCED BY LOCAL RATHER THAN SYSTEMIC MECHANISMS [J].
BRISTOW, MR ;
MINOBE, W ;
RASMUSSEN, R ;
LARRABEE, P ;
SKERL, L ;
KLEIN, JW ;
ANDERSON, FL ;
MURRAY, J ;
MESTRONI, L ;
KARWANDE, SV ;
FOWLER, M ;
GINSBURG, R .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :803-815
[6]   BETA-1-ADRENERGIC-RECEPTOR AND BETA-2-ADRENERGIC-RECEPTOR SUBPOPULATIONS IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM - COUPLING OF BOTH RECEPTOR SUBTYPES TO MUSCLE-CONTRACTION AND SELECTIVE BETA-1-RECEPTOR DOWN-REGULATION IN HEART-FAILURE- [J].
BRISTOW, MR ;
GINSBURG, R ;
UMANS, V ;
FOWLER, M ;
MINOBE, W ;
RASMUSSEN, R ;
ZERA, P ;
MENLOVE, R ;
SHAH, P ;
JAMIESON, S ;
STINSON, EB .
CIRCULATION RESEARCH, 1986, 59 (03) :297-309
[7]   REGIONAL DISTRIBUTION OF BETA-ADRENOCEPTORS IN THE HUMAN-HEART - COEXISTENCE OF FUNCTIONAL BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTOR IN BOTH ATRIA AND VENTRICLES IN SEVERE CONGESTIVE CARDIOMYOPATHY [J].
BRODDE, OE ;
SCHULER, S ;
KRETSCH, R ;
BRINKMANN, M ;
BORST, HG ;
HETZER, R ;
REIDEMEISTER, JC ;
WARNECKE, H ;
ZERKOWSKI, HR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (06) :1235-1242
[8]   Diminished responsiveness of Gs-coupled receptors in severely failing human hearts:: No difference in dilated versus ischemic cardiomyopathy [J].
Brodde, OE ;
Vogelsang, M ;
Broede, A ;
Michel-Reher, M ;
Beisenbusch-Schafer, E ;
Hakim, K ;
Zerkowski, HR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (04) :585-594
[9]   NORADRENALINE, ATRIAL NATRIURETIC PEPTIDE, BOMBESIN AND NEUROTENSIN IN MYOCARDIUM AND BLOOD OF RATS IN CONGESTIVE CARDIAC-FAILURE [J].
CECONI, C ;
CONDORELLI, E ;
QUINZANINI, M ;
RODELLA, A ;
FERRARI, R ;
HARRIS, P .
CARDIOVASCULAR RESEARCH, 1989, 23 (08) :674-682
[10]   Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase [J].
Choi, DJ ;
Koch, WJ ;
Hunter, JJ ;
Rockman, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :17223-17229